Bulk Manufacturer of Controlled Substances Application: Purisys, LLC, 41872 [2021-16500]
Download as PDF
<![CDATA[
41872
Federal Register / Vol. 86, No. 146 / Tuesday, August 3, 2021 / Notices
Public Availability of Comments
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Authority
The authority for this action is section
4(f) of the Endangered Species Act of
1973, as amended (16 U.S.C. 1531 et
seq.).
Robyn Thorson,
Regional Director, U.S. Fish and Wildlife
Service.
[FR Doc. 2021–16521 Filed 8–2–21; 8:45 am]
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
October 4, 2021.
DEPARTMENT OF JUSTICE
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
AGENCY:
DATES:
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on June 30, 2021, 1550
Olympic Drive, Athens, Georgia 30601–
1602, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
BILLING CODE 4333–15–P
Controlled
substance
DEPARTMENT OF JUSTICE
Opium, powdered.
Opium, granulated.
Drug Enforcement Administration
[Docket No. DEA–874]
Bulk Manufacturer of Controlled
Substances Application: Purisys, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
SUMMARY:
Drug code
Schedule
9639
II
9640
II
The company plans to bulk
manufacture the listed controlled
substances as Active Pharmaceutical
Ingredient (API) for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–16500 Filed 8–2–21; 8:45 am]
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–873]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Cerilliant Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 4, 2021. Such persons
may also file a written request for a
hearing on the application on or before
October 4, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on June, 24, 2021,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ..............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ..............................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
N,N-Dimethylamphetamine ..............................................................................................................................................
Fenethylline .....................................................................................................................................................................
Aminorex ..........................................................................................................................................................................
4-Methylaminorex (cis isomer) ........................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......................
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) ...............................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .......................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................
VerDate Sep<11>2014
17:21 Aug 02, 2021
Jkt 253001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
E:\FR\FM\03AUN1.SGM
03AUN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
6250
7008
7010
7011
7012
7014
7019
7020
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 86, Number 146 (Tuesday, August 3, 2021)]
[Notices]
[Page 41872]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16500]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-874]
Bulk Manufacturer of Controlled Substances Application: Purisys,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 4, 2021.
Such persons may also file a written request for a hearing on the
application on or before October 4, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on June 30, 2021, 1550 Olympic Drive, Athens, Georgia
30601-1602, applied to be registered as a bulk manufacturer of the
following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Opium, powdered.................... 9639 II
Opium, granulated.................. 9640 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances as Active Pharmaceutical Ingredient (API) for distribution
to its customers. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-16500 Filed 8-2-21; 8:45 am]
BILLING CODE P
